Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00617227 · ClinicalTrials.gov registry record
Serum Vancomycin Levels in Patients Receiving Enteral Vancomycin
A clinical trial, sponsored by Maimonides Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT00617227 is a clinical trial that has completed, run by Maimonides Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT00617227 has completed, sponsored by Maimonides Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The study is based on the hypothesis that decreased creatinine clearance may be associated with detectable vancomycin levels in patients on enteral (oral / vancomycin enemas) vancomyicn for CDAD. The objective of the study is to see whether enteral vancomycin is absorbed through the inflamed GI mucosa in CDAD, and if it is absorbed, does it achieve measurable serum concentration.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00617227
The ClinicalTrials.gov registry entry for NCT00617227 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maimonides Medical Center, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00617227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00617227 about?
NCT00617227 is a clinical study titled "Serum Vancomycin Levels in Patients Receiving Enteral Vancomycin". The study is based on the hypothesis that decreased creatinine clearance may be associated with detectable vancomycin levels in patients on enteral (oral / vancomycin enemas) vancomyicn for CDAD. The objective of the study is to see whether enteral vancomycin is absorbed through the inflamed GI muc...
What is the current status of trial NCT00617227?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2007-10. Estimated completion is 2010-02.
Who is sponsoring clinical trial NCT00617227?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.